论文部分内容阅读
近年来的研究表明,高血压病的发生和发展与体内一种具有多种生理功能的细胞内信息分子——内皮舒张因子(endothelium-derived relaxing factor,EDRF)有关。EDRF具有舒张血管、抑制平滑肌细胞增殖和抗血栓形成的作用,并且是调节血管张力、维持血压稳定的生理性血压缓冲剂。因此,EDRF与高血压病的关系已引起医学界普遍关注。据此,我们随机检测了我院10例高血压病患者(收缩压<21.3kPa,舒张压>12.7kPa)含服硝苯吡啶前后血管EDRF与血压的变化(见附
In recent years, studies have shown that the occurrence and development of hypertension and the body with a variety of physiological functions of intracellular information molecules - endothelium-derived relaxing factor (EDRF). EDRF has the functions of relaxing blood vessels, inhibiting smooth muscle cell proliferation and antithrombosis, and is a physiological blood pressure buffer that regulates blood vessel tension and maintains blood pressure stability. Therefore, the relationship between EDRF and hypertension has aroused widespread concern in the medical profession. Accordingly, we randomly detected changes in EDRF and blood pressure in 10 hypertensive patients (systolic blood pressure <21.3 kPa, diastolic blood pressure> 12.7 kPa) before and after nifedipine in our hospital (see attached